loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X

List of 042LAQ1IIS NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Fermion Oy (1)

02 Emcure Pharmaceuticals Limited (1)

03 Hetero Labs Limited (1)

04 Hubei Haosun Pharmaceutical Co., Ltd. (1)

05 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (1)

06 Laurus Labs Limited (1)

07 Olon SpA (1)

08 Qilu Pharmaceutical Co. Ltd. (1)

09 SHILPA PHARMA LIFESCIENCES LIMITED (1)

10 ScinoPharm Taiwan Ltd. (1)

11 Shandong Anxin Pharmaceutical Co., Ltd. (1)

12 Sichuan Xieli Pharmaceutical Co., Ltd. (1)

filter

01 IRINOTECAN HYDROCHLORIDE (1)

02 Irinotecan (1)

03 Irinotecan HCl (1)

04 Irinotecan Hydrochloride (7)

05 Irinotecan Hydrochloride Trihydrate (2)

filter

01 China (4)

02 Finland (1)

03 India (4)

04 Italy (1)

05 Taiwan (1)

06 United Kingdom (1)

IRINOTECAN HYDROCHLORIDE
POWDER (1kg/kg)
BULK INGREDIENT
12780-4860
2007-06-29
2024-12-31
URL Supplier Web Content
Irinotecan HCl
POWDER (5kg/5kg)
BULK INGREDIENT
14593-828
2023-12-25
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER (1g/g)
BULK INGREDIENT
14778-1111
2011-10-10
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
57884-0009
2007-08-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride Trihydrate
POWDER (1kg/kg)
BULK INGREDIENT
42385-711
2008-11-21
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
17337-0307
2012-03-02
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
67184-0014
2021-10-08
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER (3kg/3kg)
BULK INGREDIENT
35369-0020
2023-07-05
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
65129-1025
2003-07-31
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Irinotecan Hydrochloride
POWDER, FOR SUSPENSION (1kg/kg)
BULK INGREDIENT FOR ...
61200-112
2015-05-14
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 100286-90-6 / Irinotecan Hydrochloride API manufacturers, exporters & distributors?

Irinotecan Hydrochloride manufacturers, exporters & distributors 1

58

PharmaCompass offers a list of Irinotecan Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Irinotecan Hydrochloride manufacturer or Irinotecan Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Irinotecan Hydrochloride manufacturer or Irinotecan Hydrochloride supplier.

PharmaCompass also assists you with knowing the Irinotecan Hydrochloride API Price utilized in the formulation of products. Irinotecan Hydrochloride API Price is not always fixed or binding as the Irinotecan Hydrochloride Price is obtained through a variety of data sources. The Irinotecan Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Irinotecan Hydrochloride

Synonyms

100286-90-6, Irinotecan hcl, Topotecin, Campto, Camptothecin 11 hydrochloride, Camptosar

Cas Number

100286-90-6

Unique Ingredient Identifier (UNII)

06X131E4OE

About Irinotecan Hydrochloride

A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.

042LAQ1IIS Manufacturers

A 042LAQ1IIS manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 042LAQ1IIS, including repackagers and relabelers. The FDA regulates 042LAQ1IIS manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 042LAQ1IIS API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 042LAQ1IIS manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

042LAQ1IIS Suppliers

A 042LAQ1IIS supplier is an individual or a company that provides 042LAQ1IIS active pharmaceutical ingredient (API) or 042LAQ1IIS finished formulations upon request. The 042LAQ1IIS suppliers may include 042LAQ1IIS API manufacturers, exporters, distributors and traders.

click here to find a list of 042LAQ1IIS suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

042LAQ1IIS NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 042LAQ1IIS as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 042LAQ1IIS API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 042LAQ1IIS as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 042LAQ1IIS and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 042LAQ1IIS NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 042LAQ1IIS suppliers with NDC on PharmaCompass.

042LAQ1IIS Manufacturers | Traders | Suppliers

042LAQ1IIS Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY